Convatec is a global medical products and technologies company focused on solutions for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence care and infusion care.
Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.
~10,000 employees
$2.289 billion revenues in 2024
FTSE100 listing
7 manufacturing sites
~900M products sold
sold in almost 90 countries
Our geographic revenue split
57%
North America
29%
Europe
14%
Rest of World
| Argentina | Colombia | Guatemala | Puerto Rico |
| Aruba | Costa Rica | Honduras | St. Maarten |
| Bolivia | Curacao | Mexico | Uruguay |
| Brazil | Dominican Republic | Panama | USA |
| Canada | Ecuador | Paraguay | |
| Chile | El Salvador | Peru |
| Andorra | Finland | Malta | Slovenia |
| Austria | France | Netherlands | Spain |
| Belgium | Germany | North Macedonia | Sweden |
| Bosnia & Herzegovina | Greece | Norway | Switzerland |
| Bulgaria | Hungary | Poland | Turkey |
| Croatia | Iceland | Portugal | Ukraine |
| Cyprus | Italy | Republic of Ireland | United Kingdom |
| Czech Republic | Latvia | Romania | |
| Denmark | Lithuania | Serbia | |
| Estonia | Luxenbourg | Slovakia |
| Australia | Indonesia | New Zealand | 台灣地區 (Taiwan) |
| China | Japan | Philippines | Thailand |
| 香港特區 (Hong Kong SAR) | Malaysia | Singapore | Vietnam |
| India | Mauritius | South Korea |
| Bahrain | Israel | Lebanon | Saudi Arabia |
| Egypt | Jordan | Oman | South Africa |
| Iran | Kenya | Pakistan | Tunisia |
| Iraq | Kuwait | Qatar | UAE |